Zachary Zinn, MD
Dermatology · Morgantown, WVNPI 1285876011
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,588 of the $3,978 with a category attached, or 65.0%. Lilly USA, LLC accounts for 65.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $2,588 and has fallen 88.3% since, to $304 in 2025.
Across 19 payments — averaging $209.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$3K
- Nobelpharma America, LLC$400
- Journey Medical Corporation$318
- AstraZeneca$288
- Regeneron Healthcare Solutions, Inc.$125
- Krystal Biotech Inc$88
- plus $172 from 4 others
Across 64 payments — averaging $3394.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$217K
What the payments were for
- Consulting fees$2,58865%
- Speaking & faculty fees$40010%
- Food & beverage$99125%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 1 | $2,588 |
| Nobelpharma America, LLC | 1 | $400 |
| Journey Medical Corporation | 4 | $318 |
| AstraZeneca | 5 | $288 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Krystal Biotech Inc | 1 | $88 |
| Novartis | 2 | $52 |
| Janssen Scientific Affairs, LLC | 1 | $50 |
| AbbVie | 2 | $43 |
| Verrica Pharmaceuticals Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,978 in reported general payments places this provider in the 60th percentile of 39 dermatology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 14 | $399 |
| Clobetasol Propionate | 13 | $279 |
| Triamcinolone Acetonide | 11 | $190 |
| Doxycycline Hyclate | 17 | $165 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Morgantown
- Rola GharibMorgantown$393K
- Kenneth HardyMorgantown$13K
- Michele MaouadMorgantown$6K
- Amy NortonMorgantown$5K
- Samantha JenkinsMorgantown$2K
- Mary HallMorgantown$2K
- Roxann PowersMorgantown$340
- Erica GhareebMorgantown$302
- Jessica PattersonMorgantown$239
- Christine DeeMorgantown$238
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.